Clinical Trial Update: Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating hydroxychloroquine as an autophagy blocker in men with prostate cancer undergoing surgery or active surveillance, which has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Prostate Carcinoma | EARLY_Phase 1 | Status: TERMINATED